Dexamethasone therapy in patients with brain tumors--a focus on tapering

J Neurosci Nurs. 2004 Dec;36(6):340-3. doi: 10.1097/01376517-200412000-00008.

Abstract

Administration of corticosteriods in brain tumor patients requires an understanding of the physiology of the adrenal system and desired patient response. Close attention to other concomitant medications will ensure adequate amounts of all drugs, including dexamethasone. Nurses need to assess patients' tolerance of dexamethasone, discuss these findings with physicians and pharmacists, and educate both patients and family members on doses and tapering schedules tailored to individual patient needs.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / nursing
  • Dexamethasone / administration & dosage*
  • Dexamethasone / adverse effects
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / adverse effects
  • Humans
  • Substance Withdrawal Syndrome / nursing
  • Substance Withdrawal Syndrome / prevention & control*

Substances

  • Glucocorticoids
  • Dexamethasone